This review aims to highlight various cell- and gene-based therapeutic approaches leading to the generation of new insulin-producing cells as a topmost “panacea” for treating diabetes, while deliberately avoiding a detailed molecular description of these approaches. This evidence concerns the gene INS and diabetes mellitus.